Clinical Trial Update: 9-ING-41 in Patients With Advanced Cancers [Phase 2]

View source ↗

Summary

Actuate Therapeutics' Phase 2 trial of 9-ING-41 in patients with advanced cancers is currently active but not recruiting, with pancreatic cancer among the liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Malignant Glioma
• Non-hodgkin Lymphoma
• Pancreatic Cancer
• Renal Cell Carcinoma
• Sarcoma

Drugs mentioned

• 9-ING-41

Snippet

Sponsor: Actuate Therapeutics Inc. | Conditions: Cancer, Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING